Previous 10 | Next 10 |
2023-11-28 09:16:30 ET More on 180 Life Sciences Financial information for 180 Life Sciences For further details see: 180 Life Sciences announces review of strategic alternatives
PALO ALTO, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that its Board of Directors has initiated a process to evaluate potential strategic alternatives with the intent to unloc...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
180 Life Sciences Corp. (ATNF) is expected to report for Q1 2024
2023-09-29 10:00:00 ET More on psychedelic drugs Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies With ecstasy a potential PTSD therapy, psychedelic treatments could take off Psychedelic Stocks = Super-Risky Biote...
2023-09-26 13:17:43 ET More on psychedelic drug development Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets. COMPASS: The Landscape Is Changing Qui...
2023-09-16 16:00:56 ET On Sept. 14, the Multidisciplinary Association for Psychedelic Studies ("MAPS") announced positive results on a second phase 3 trial for MDMA -- also known as ecstasy -- for post-traumatic stress disorder that were published in a scientific journal. The data in th...
2023-08-31 12:35:49 ET More on psychedelic drugmakers Compass Pathways: Debt Deal Secured, Cash Runway Extended COMPASS Pathways plc ( CMPS ) Q2 2023 Earnings Call Transcript Mind Medicine Inc. ( MNMD ) Q2 2023 Earnings Call Transcript Psychedelic Sto...
2023-08-22 12:50:11 ET More on psychedelic drug companies Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets. COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down Psychedelic Stocks: Don't Bet On Just 1 Company Seelos:...
180 Life Sciences (NASDAQ: ATNF) , a clinical-stage biotechnology company, has closed on its previously announced public offering. The offering was comprised of 4,615,385 shares of the company’s common stock (or common stock equivalents in lieu thereof) as well as warrants to purchase up t...
News, Short Squeeze, Breakout and More Instantly...
180 Life Sciences Corp Com Company Name:
ATNF Stock Symbol:
NASDAQ Market:
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 92.8% to $0.1153 on volume of 395,102,952 shares Crown Electrokinetics Corp. (CRKN) rose 60.2% to $0.074 on volume of 250,418,429 shares Pineapple Energy Inc. (PEGY) rose 68.4% to $0.146...
180 Life Sciences (NASDAQ: ATNF) today announced that it received a letter on March 13, 2024, from the Nasdaq Stock Market LLC indicating that the company has regained full compliance with the minimum bid price for continued listing on the Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) ( ...
2024-02-27 08:02:12 ET 180 Life Sciences Corp (ATNF) announced stock split at a ratio of 1-for-19 on 2024-02-28 ... Full story available on KlickAnalytics.com